Background Sudden cardiac death among children and young adults is a devastating event.
We performed a prospective, population-based, clinical and genetic study of sudden …

Background: Genetic testing for families with hypertrophic cardiomyopathy (HCM) provides
a significant opportunity to improve care. Recent trends to increase gene panel sizes often …

Arrhythmogenic cardiomyopathy (ACM) is an arrhythmogenic disorder of the myocardium not
secondary to ischemic, hypertensive, or valvular heart disease. ACM incorporates a broad …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient’s interest, …

Background: Each of the cardiomyopathies, classically categorized as hypertrophic
cardiomyopathy, dilated cardiomyopathy (DCM), and arrhythmogenic right ventricular …

While the inherited cardiomyopathies and primary arrhythmogenic disorders are distinctly
different diseases, the genetic counseling issues can be very similar. 14 Collectively, these …

Background : Whole genome sequencing (WGS) is a comprehensive genetic testing approach
that reports most types of nucleotide variants. Objectives : This study sought to assess …

Background Traditional management of families with hypertrophic cardiomyopathy (HCM)
involves periodic lifetime clinical screening of family members, an approach that does not …

Hypertrophic cardiomyopathy (HCM) is an important genetic heart muscle disease for which
prevalence in the general population has not been completely resolved. For the past 20 …

Objective: To report the frequency of single and multiple gene mutations in an Australian
cohort of patients with hypertrophic cardiomyopathy (HCM). Methods: Genetic screening of …